An opinion presented to the Court of Justice of the European Union on the patentability of parthenotes challenges the court's own competence in a notorious case on human embryonic stem cells.
Get full access to this article
View all access options for this article.
References
1.
RevazovaES, TurovetsNA, KochetkovaOD, KindarovaLB, KuzmichevLN, JanusJD and PryzhkovaMV. (2007). Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells, 9:432–449.
